Related references
Note: Only part of the references are listed.Comparative study on the efficacy and safety of alteplase and urokinase in the treatment of acute cerebral infarction
Hua Bao et al.
TECHNOLOGY AND HEALTH CARE (2021)
Comparative study of intravenous thrombolysis with rt-PA and urokinase for patients with acute cerebral infarction
Fan Sun et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers et al.
STROKE (2019)
Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial
Nicola Logallo et al.
LANCET NEUROLOGY (2017)
Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke
C. S. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial
Gregory W. Albers et al.
LANCET NEUROLOGY (2015)
Intravenous thrombolysis guided by a telemedicine consultation system for acute ischaemic stroke patients in China: the protocol of a multicentre historically controlled study
Ziwen Yuan et al.
BMJ OPEN (2015)
Review of Stroke Thrombolytics
Andrew Bivard et al.
JOURNAL OF STROKE (2013)
Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke
Joanna M. Wardlaw et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study
Werner Hacke et al.
LANCET NEUROLOGY (2009)
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
Werner Hacke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Share Paper
